Role of Krüppel-like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells

IUBMB Life

Volumn 62, Issue 2, 2010, Pages 132-139

  Zheng, Bin ^a   Han, Mei ^a   Wen, Jin Kun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

KLF4; Phenotype; Proliferation; Vascular smooth muscle cells

Indexed keywords

KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR;

CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA SEQUENCE; DNA SYNTHESIS; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; UBIQUITINATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CYTOLOGY; DRUG EFFECT; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE;

EID: 77949668668     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.298     Document Type: Review

References (62)

1. Andrés, V. (2004) Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential. Cardiovasc. Res. 63, 11-21.
2. Rosner, D., Stoneman, V., Littlewood, T., McCarthy, N., Figg, N., Wang, Y., Tellides, G., and Bennett, M. (2006) Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism. Am. J. Pathol. 168, 2054-2063.
3. Kawai-Kowase, K., and Owens, G. K. (2007) Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 292, C59-C69.
4. Lagna, G., Ku, M. M., Nguyen, P. H., Neuman, N. A., Davis, B. N., and Hata, A. (2007) Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J. Biol. Chem. 282, 37244-37255.
5. Owens, G. K. (2007) Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis. Found. Symp. 283, 174-191.
6. Pagano, P. J., and Gutterman, D. D. (2007) The adventitia: the outs and ins of vascular disease. Cardiovasc. Res. 75, 636-639.
7. Autieri, M. V. (2008) Kruppel-like factor 4: transcriptional regulator of proliferation, or inflammation, or differentiation, or all three? Circ. Res. 102, 1455-1457.
8. Paravicini, T. M., and Touyz, R. M. (2006) Redox signaling in hypertension. Cardiovasc. Res. 71, 247-258.
9. Kumar, M. S., and Owens G. K. (2003) Combinatorial control of smooth muscle-specific gene expression. Arterioscler. Thromb. Vasc. Biol. 23, 737-747.
10. Munoz-Garcia, B., Martin-Ventura, J. L., Martinez, E., Sanchez, S., Hernandez, G., Ortega, L., Ortiz, A., Egido, J., and Blanco-Colio, L. M. (2006) Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin. Stroke. 37, 2044-2053. (Pubitemid 44309902)
11. Owens, G. K., Kumar, M. S., and Wamhoff B. R. (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801.
12. Haldar, S. M., Ibrahim, O. A., and Jain M. K. (2007) Kruppel-like Factors (KLFs) in muscle biology. J. Mol. Cell. Cardiol. 43, 1-10.
13. Suzuki, T., Aizawa, K., Matsumura, T., and Nagai, R. (2005) Vascular implications of the Kruppel-like family of transcription factors. Arterioscler. Thromb. Vasc. Biol. 25, 1135-1141.
14. SenBanerjee, S., Lin, Z., Atkins, G. B., Greif, D., Rao, M. R. M., Kumar, A., Feinberg, M. W., Chen, Z., Simon, D. I., Luscinskas, F. W., Michel, T. M., Gimbrone, M. A., Garcia-Cardena, G., and Jain, M. K. (2004) KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199, 1305-1315.
15. Aizawa, K. Suzuki, T. Kada, Ishihara, N. A., Kawai-Kowase, K., Matsumura, T., Sasaki, K., Munemasa, Y., Manabe, I., Kurabayashi, M., Collins, T., and Nagai, R. (2004) Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5: new pathway of cooperative activation with nuclear factor-kappaB. J. Biol. Chem. 279, 70-76.
16. Watanabe, N., Kurabayashi, M., Shimomura, Y., Kawai-Kowase, K., Hoshino, Y., Manabe, I., Watanabe, M., Aikawa, M., Kuro-o, M., Suzuki, T., Yazaki, Y., and Nagai, R. (1999) BTEB2, a Kruppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ. Res. 85, 182-191.
17. Hamik, A., Lin, Z., Kumar, A., Balcells, M., Sinha, S., Katz J., Feinberg, M.W., Gerszten, R. E., Edelman, E. R., and Jain, M. K. (2007) Kruppel-like factor 4 regulates endothelial inflammation. J. Biol. Chem. 282, 13769-13779.
18. Feinberg, M. W., Cao, Z., Wara, A. K., Lebedeva, M. A., Senbanerjee, S., and Jain M. K. (2005) Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem. 280, 38247-38258.
19. Feinberg, M. W., Lin, Z., Fisch, S., and Jain M. K. (2004) An emerging role for Kruppel-like factors in vascular biology. Trends Cardiovasc. Med. 14, 241-246.
20. Liu, Y., Sinha, S., McDonald, O. G., Shang, Y., Hoofnagle, M. H., and Owens, G. K. (2005) Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J. Biol. Chem. 280, 9719-9727.
21. Yan, F. F., Liu, Y. F., Liu, Y., and Zhao, Y. X. (2008) KLF4: a novel target for the treatment of atherosclerosis. Med. Hypotheses. 70, 845-847.
22. Liu, Y., Sinha, S., and Owens G. K. (2003) A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J. Biol. Chem. 278, 48004-48011.
23. Zhao, X. M., Dong, L. H., Meng, F., Zheng, B., Wen, J. K., and Han M. (2009) Exogenous KLF4 inhibits neointimal hyperplasia after balloon injury in rat. Chinese. J. Pathophysiol. 25, 1303-1306.
24. Zheng, B., Han, M., Bernier, M., Zhang, X. H., Meng, F., Miao, S. B., He, M., Zhao, X. M., and Wen J. K. (2009) Krüppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells. J. Biol. Chem. 284, 22773-22785.
25. Wei, D., Kanai, M., Huang, S., and Xie, K. (2006) Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis. 27, 23-31. (Pubitemid 43032979)
26. Yoshida, T., Kaestner, K. H., and Owens, G. K. (2008) Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ. Res. 102, 1548-1557.
27. Andrés, V. (2004) Unexpected proatherogenic properties of p21: beyond cell cycle control? Circulation. 110, 3749-3752.
28. Zhang, W., Geiman, D. E., Shields, J. M., Dang, D. T., Mahatan, C. S., Kaestner, K. H., Biggs, J. R., Kraft, A. S., and Yang, V. W. (2000) The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter, J. Biol. Chem. 275, 18391-18398.
29. Wassmann, S., Wassmann, K., Jung, A., Velten, M., Knuefermann, P., Petoumenos, V., Becher, U., Werner, C., Mueller, C., and Nickenig, G. (2007) Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells, J. Mol. Cell. Cardiol. 43, 301-307. (Pubitemid 47301935)
30. Wang, C., Han, M., Zhao, X. M., and Wen, J. K. (2008) Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. J. Biochem. 144, 313-321.
31. Saifudeen, Z., Dipp, S., Fan, H., and El-Dahr, S. S. (2005) Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation. Am. J. Physiol. Renal. Physiol. 288, F899-F909.
32. Wassmann, K., Mueller, C. F. H., Becher, U. M., Werner, C., Jung, A., Zimmer, S., Steinmetz, M., Nickenig, G., and Wassmann, S. (2010) Interaction of Inhibitor of DNA binding 3 (Id3) with Gut-enriched Krupel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cells. Mol. Cell. Biochem. 333, 33-39.
33. Stenmark, K. R., and Mecham, R. P. (1997) Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu. Rev. Physiol. 59, 89-144.
34. Rzucidlo, E. M., Martin, K. A., and Powell, R. J. (2007) Regulation of vascular smooth muscle cell differentiation. J. Vasc. Surg. 45, A25-A32.
35. Sartore, S., Franch, R., Roelofs, M., and Chiavegato, A. (1999) Molecular and cellular phenotypes and their regulation in smooth muscle. Rev. Physiol. Biochem. Pharmacol. 134, 235-320.
36. Stegemann, J. P., Hong, H., and Nerem, R. M. (2005) Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J. Appl. Physiol. 98, 2321-2327.
37. Adam, P. J., Regan, C. P., Hautmann, M. B., and Owens, G. K. (2000) Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J. Biol. Chem. 275, 37798-37806.
38. King, K. E., Iyemere, V. P., Weissberg, P. L., and Shanahan, C. M. (2003) Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J. Biol. Chem. 278, 11661-11669.
39. Ai, W., Liu, Y., Langlois, M., and Wang, T. C. (2004) Kruppel-like factor 4 (KLF4) represses histidine decarboxylase gene expression through an upstream Sp1 site and downstream gastrin responsive elements. J. Biol. Chem. 279, 8684-8693.
40. Lu, J., Goldstein, K. M., Chen, P., Huang, S., Gelbert, L. M., and Nagpal, S. (2005) Transcriptional profiling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network. J. Invest. Dermatol. 124, 778-785.
41. Deaton, R. A., Gan, Q., and Owens, G. K. (2009) Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am. J. Physiol. Heart. Circ. Physiol. 296, H1027-H1037.
42. Yoshida, T., Gan, Q., and Owens, G. K. (2008) Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell. Physiol. 295, C1175-C1182.
43. Kaplan-Albuquerque, N., Bogaert, Y. E., Van Putten, V., Weiser-Evans, M. C., and Nemenoff, R. A. (2005) Patterns of gene expression differentially regulated by platelet-derived growth factor and hypertrophic stimuli in vascular smooth muscle cells: markers for phenotypic modulation and response to injury. J. Biol. Chem. 280, 19966-19976.
44. Philippar, U., Schratt, G., Dieterich, C., Muller, J. M., Galgoczy, P., Engel, F. B., Keating, M. T., Gertler, F., Schule, R., Vingron, M., and Nordheim, A. (2004) The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol. Cell. 16, 867-880.
45. Pidkovka, N. A., Cherepanova, O. A., Yoshida, T., Alexander, M. R., Deaton, R. A.,. Thomas, J. A, Leitinger, N., and Owens, G. K. (2007) Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ. Res. 101, 792-801.
46. Wang, Z., Wang, D. Z., Hockemeyer, D., McAnally, J., Nordheim, A., and Olson, E. N. (2004) Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature. 428, 185-189. (Pubitemid 38374315)
47. Zhou, J., Hu, G., and Herring B. P. (2005) Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol. Cell. Biol. 25, 9874-9885.
48. Sandbo, N., Qin, Y., Taurin, S., Hogarth, D. K., Kreutz, B., and Dulin, N. O. (2005) Regulation of serum response factor-dependent gene expression by proteasome inhibitors. Mol. Pharmacol. 67, 789-797.
49. McDonald, O. G., Wamhoff, B. R., Hoofnagle, M. H., and Owens, G. K. (2006) Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Invest. 116, 36-48.
50. Yoshida, T., Hoofnagle, M. H., and Owens, G. K. (2004) Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ. Res. 94, 1075-1082.
51. Wang, D. Z., Li, S., Hockemeyer, D., Sutherland, L., Wang, Z., Schratt, G., Richardson, J. A., Nordheim, A., and Olson, E. N. (2002) Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. USA 99, 14855-14860.
52. Doi, H., Iso, T., Yamazaki, M., Akiyama, H., Kanai, H., Sato, H., Kawai-Kowase, K., Tanaka, T., Maeno, T., Okamoto, E., Arai, M., Kedes, L., and Kurabayashi, M. (2005) HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler. Thromb. Vasc. Biol. 25, 2328-2334.
53. Wang, Z., Wang, D. Z., Pipes, G. C., and Olson, E. N. (2003) Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. USA 100, 7129-7134.
54. Meng, F., Han, M., Zheng, B., Wang, C., Zhang, R., Zhang, X. H., and Wen, J. K. (2009) All-trans retinoic acid increases KLF4 acetylation by inducing HDAC2 phosphorylation and its dissociation from KLF4 in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 387, 13-18.
55. Kawai-Kowase, K., Ohshima, T., Matsui, H., Tanaka, T., Shimizu, T., Iso, T., Arai, M., Owens, G. K., and Kurabayashi, M. (2009) PIAS1 mediates TGF beta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Arterioscler. Thromb. Vasc. Biol. 29, 99-106.
56. Kee, H.J., and Kook, H. (2009) Kruppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. J. Mol. Cell Cardiol. 47, 770-780.
57. Evans, P.M., Zhang, W., Chen, X., Yang J., Bhakat, K.K., Liu, C. (2007) Krüppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J. Biol. Chem. 282, 33994-34002.
58. Bieker, J. J. (2001) Kruppel-like factors: three fingers in many pies. J. Biol. Chem. 276, 34355-34358.
59. Conkright, M. D., Wani, M. A., Anderson, K. P., and Lingrel, J. B. (1999) A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cell. Nucleic Acids. Res. 27, 1263-1270.
60. Sun, R., Chen, X., and Yang, V. W. (2001) Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J. Biol. Chem. 276, 6897-6900.
61. Fujiu, K., Manabe, I., Ishihara, A., Oishi, Y., Iwata, H., Nishimura, G., Shindo, T., Maemura, K., Kagechika, H., Shudo, K., and Nagai, R. (2005) Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ. Res. 97, 1132-1141.
62. Shindo, T., Manabe, I., Fukushima, Y., Tobe, K., Aizawa, K., Miyamoto, S., Kawai-Kowase, K., Moriyama, N., Imai, Y., Kawakami, H., Nishimatsu, H., Ishikawa, T., Suzuki, T., Morita, H., Maemura, K., Sata, M., Hirata, Y., Komukai, M., Kagechika, H., Kadowaki, T., Kurabayashi, M., and Nagai, R. (2002) Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8, 856-863.